Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-03-24
1983-08-23
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560 56, 560100, 560102, 560107, 560117, 560256, 562466, 562499, 424311, 424317, 556438, 549420, 549475, C07C 5946, C07C 69753, A01K 31215
Patent
active
044003935
ABSTRACT:
A novel bicyclooctane derivative represented by the formula: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1-4 alkyl, X is ethylene or vinylene, and Y.sub.1 and Y.sub.2 are independently hydrogen or a hydroxyl-protecting group, or a pharmaceutically acceptable salt of said compound in which R.sub.1 is hydrogen. Said compound and pharmaceutically acceptable salt are chemically stable, have platelet anti-aggregation activity without undesirable pharmacological actions and exhibit the duration of high biological activity.
Katsube Junki
Kawakami Hajime
Kojima Atsuyuki
Ono Keiichi
Sami Shunsuke
Gerstl Robert
Sumitomo Chemical Company Limited
LandOfFree
Novel bicyclooctane compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel bicyclooctane compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel bicyclooctane compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1947212